CLIG — City of London Investment Group PLC

Executive summary

CLIG is a specialist active asset manager that invests primarily via closed-end funds (CEFs), split between CLIM (institutional equity, especially EM and International) and KIM (US HNW balanced/fixed income), with $12.3bn of FuM at 30 June 2026 2026-07-23 pre-close. Operating trajectory has been resilient — underlying profits grew ~13% in FY25 to $30.8m 2025-09-16 finals and H1 FY26 underlying PBT rose 7% to $16.2m despite persistent net outflows, largely offset by strong market performance and above-benchmark alpha 2026-02-24 interim. The single most important valuation point today: the share price has re-rated ~37% over the past year to 486p, taking the stock to roughly fair value on a ~12x forward underlying earnings basis, with a ~6.8% dividend yield underpinned by a debt-free, cash-generative balance sheet.

Fair value estimate

• Fair value range: 420p – 520p per share → implied market cap £207m – £257m.
• Midpoint: ~470p → ~£232m.
• Methodology: multiple of forward underlying earnings, cross-checked against AUM/mcap ratio and dividend yield.
• Assumptions: H1 FY26 underlying EPS was 19.5p; annualising and allowing modest H2 seasonality suggests FY26 underlying EPS of 37–40p. Applying an 11–13x multiple (appropriate for a small-cap, mid-quality asset manager with modest growth and a high dividend yield) yields the range. Cross-check: market cap of £238m on FuM of $12.3bn (£9.2bn) is ~2.6% of AUM, in the mid-range for specialty active managers. Dividend yield at 33p/share = 6.8% at 486p; at 470p, ~7.0%.
• Compared to current market cap of £238m: the stock trades in the upper half of the fair-value range.
• Absolute upside/downside vs 486p midpoint 470p: –3.3% (essentially fair, mild premium). Range implies –14% to +7%.

Sector context

• Sector: Financial Services (Asset Management), confirmed.
• CLIG's quality profile is above typical UK small-cap asset managers on balance-sheet strength (debt-free, $32.8m cash), dividend consistency (33p maintained for four years, plus specials) and disclosure. Growth is in line with peers (mid-single-digit organic growth largely dependent on markets). Operating leverage is in line; margins are strong but scale is limited.
• Listed peers: Liontrust Asset Management (LIO), Polar Capital (POLR), Impax Asset Management (IPX). All UK-listed active managers facing similar structural pressures from passive/ETF flows.

Investment thesis

• Attractive dividend yield backed by a fortress balance sheet. 33p annual dividend on 486p share price = ~6.8% yield, with $32.8m cash and no debt at 31 Dec 2025 2026-02-24 interim. Rolling five-year dividend cover of 1.21x on underlying profits 2025-09-16 finals provides discipline through cycles.
• Diversified, alpha-generating franchise post-Karpus merger. KIM merger (Oct 2020) reduced EM equity concentration from ~90% of FuM in 2016 to ~37% today 2025-02-24 interim. Both CLIM and KIM show strong long-term relative performance, with EM outperforming benchmark by 540bps and Listed PE by 1620bps in H1 FY26 2026-01-19 trading update.
• Fee franchise showing operating leverage from FuM recovery. FuM has risen from a $8.4bn trough in Oct 2022 to $12.3bn at Jun 2026 — an all-time high 2026-02-24 interim, 2026-07-23 pre-close. Net fee income grew 6% in H1 FY26 on 9% higher average FuM, and underlying EPS rose 14% in dollar terms — evidence of operating leverage kicking in as FuM scales.

Key risks

• Persistent net outflows despite strong performance. Net outflows of $1.3bn in FY26 despite in-line-to-strong performance across strategies 2026-07-23 pre-close; $974m in FY25; $853m in H1 FY25. If markets weaken, positive market/investment performance would no longer mask organic decline, and revenue could contract sharply.
• Concentrated in a structurally challenged asset class. ~35% of Group FuM is in Emerging Markets equity, which has lagged US equities for over a decade 2025-02-24 interim. "EM fatigue" from allocators is explicitly acknowledged. CEF discounts wide but historically slow to normalise. Also, a Controlling Shareholder Group holds >30% (voting capped at 24.99%) 2025-10-27 AGM — reduces takeover optionality.
• Structural headwinds from passive/ETF migration and regulatory burden. Prior CEO (Feb 2024 interim) noted the "meaningful burden" of UK listing and industry-wide shift from active to passive. The 2020s active-to-passive flows challenge asset managers of this profile [not disclosed in specific numeric detail but explicitly flagged by former CEO].

Operating leverage

CLIG has moderate-to-high operating leverage typical of an asset manager. In FY25, net fee income of $69.8m was earned against overheads (before variable comp) of $27.9m — a fixed-ish overhead base of roughly 40% of net fee income 2025-09-16 finals. Cost-income ratio (fixed cost basis) improved 2.1ppt YoY to 40.1% in FY25 as revenue grew and management held costs flat. The Group also runs a variable profit-share ($10.8m FY25) which flexes with profitability, providing downside protection but muting upside operating leverage. If FuM were to grow 10-20% above expectations from current $12.3bn — say to $13.5-14.7bn — average revenue would rise 10-15%, and I'd estimate operating profit could rise 20-35% given the semi-fixed cost base, absent significant compensation ratchet. The natural inflection point is scale — CLIG estimates ~$6bn of spare capacity in existing CEF strategies 2024-09-24 finals which could be filled without proportional cost growth. Not the "multiples of profit on 10-20% revenue beat" the investor wants; more like ~1.5-2x profit sensitivity to revenue.

Value-trap signals

• Chronic net outflows for four consecutive years (FY22–FY26): –$102m, +$102m, –$357m, –$320m, –$974m, –$1,336m — a worsening trend despite good performance.
• Structural pressure on active asset management from passive flows.
• Controlling shareholder group limits M&A/takeover optionality and constrains float.
• However: no debt, consistent profitability, strong dividend cover — not a classic value trap.

Earnings vs expectations

CLIG does not provide formal quantitative EPS guidance, and I found no analyst consensus figures cited in the filings. Pattern from the disclosure: the pre-close trading updates typically flag directional trends (dividend maintained "in line with previous year") and management delivers on stated dividend commitments consistently. H1 FY26 delivered underlying PBT +7% YoY on FuM +9% avg — a mechanical result consistent with markets and flows rather than a beat/miss framework. Not enough data to score meaningfully in a beat/meet/miss framework; company runs a stability-first culture rather than a guide-and-beat one.

Conviction

Conviction: 4 (high).

• Anchors: (i) Clean, well-disclosed financials with a straightforward AUM × fee-rate revenue model; (ii) simple multi-year track record — FuM, EPS and dividends are all reported consistently over 5+ years; (iii) two valuation methods (P/E on underlying earnings ~12x, AUM ratio ~2.6%) converge on a similar fair value near current price.
• Limits: (i) forward earnings depend on capricious variables — market direction and net flows — that could invalidate the point estimate quickly; (ii) sterling/dollar translation adds noise given ~65% of costs in USD.

Driver scoring

CLIG is fundamentally misaligned with the investor's AI-beneficiary strategy. It is a specialty active asset manager — the value flows to the asset owners' underlying holdings, not to CLIG itself. The company's own filings acknowledge AI as a market theme benefiting the Korean/Taiwanese equities held via CEFs, but this does not translate into a durable revenue driver for CLIG. Balance-sheet quality and dividend yield are strong, but the strategic fit is poor.